ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

Disease Oriented Programs Must Be Coordinated: Rabson

October 15, 1976

CCOP Review Completed; 72 Applications Submitted, 23 More For Minority CCOP

December 1, 1989

NCI Cooperative Group Clinical Trials Approved

February 26, 2010

In Brief: Barbara Britt Assumes ONS Presidency, O’Conner Is President-Elect; Kalt Joins NCI

May 25, 1990

Kulig Will Oversee Outcomes Research at NCCN

September 30, 2011

NCI Seeks Nominations For Consumer Liaison Group.

November 23, 2001